60 Degrees Pharmaceuticals Inc. Revenue 2020–2025
60 Degrees Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- 60 Degrees Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 162092, a 0.89% decrease year-over-year.
- 60 Degrees Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 1.0 M.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2025 was 1.0 M, a 65.49% increase from 2024.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2024 was 607574, a 139.61% increase from 2023.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2023 was 253573, a 13.60% increase from 2022.
- 60 Degrees Pharmaceuticals Inc. annual revenue for 2022 was 223208.
60 Degrees Pharmaceuticals Inc. (SXTP) — Frequently Asked Questions
60 Degrees Pharmaceuticals Inc. (SXTP) is a publicly traded US company. It has a market capitalization of $2M. In fiscal 2025 it reported revenue of $1M and net income of -$7M. Explore SXTP's stock price, financial statements, earnings history, margins and key ratios below.
What is 60 Degrees Pharmaceuticals Inc.'s market cap?
60 Degrees Pharmaceuticals Inc. (SXTP) has a market capitalization of $2M.
What is the SXTP stock price?
SXTP trades at $1.38 (-0.72% on the day).
How much revenue does 60 Degrees Pharmaceuticals Inc. make?
60 Degrees Pharmaceuticals Inc. reported revenue of $1M in fiscal 2025.
Is SXTP profitable?
In fiscal 2025, 60 Degrees Pharmaceuticals Inc. reported net income of -$7M.